Matrix Trust Company’s Amgen AMGN Stock Holding History

Matrix Trust Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-136	Closed	-$45K	–	180
2025 Q4	$45K	Sell	136 -519	-79%	-$165K	0.01%	123
2025 Q3	$185K	Buy	655 +7	+1%	+$2.03K	0.03%	129
2025 Q2	$181K	Buy	648 +135	+26%	+$38.2K	0.03%	134
2025 Q1	$160K	Buy	513 +54	+12%	+$15.9K	0.03%	135
2024 Q4	$120K	Buy	459 +346	+306%	+$103K	0.02%	129
2024 Q3	$36K	Buy	+113	New	+$37K	0.01%	93

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Matrix Trust Company's AMGN Position: Q1 2026 in Review

Matrix Trust Company sold out of Amgen (AMGN) in Q1 2026, closing a stake of 136 shares — an estimated $45K sold.

Matrix Trust Company first reported a position in AMGN in Q3 2024 and held it in 6 quarters. The position peaked at $185K in Q3 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Matrix Trust Company reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Matrix Trust Company sold 136 Amgen shares in Q1 2026, an estimated $45K.
Matrix Trust Company first reported a position in Amgen in Q3 2024 and held it in 6 quarters.
Matrix Trust Company's Amgen position peaked at $185K in Q3 2025.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Matrix Trust Company's 13F filing for Q1 2026, filed 10 Apr 2026.